India's pharmaceutical sector, renowned for its budget-friendly medications and vast manufacturing capabilities, faces a growing concern: monopolies. While generic drug production has been a cornerstone of India's success, certain companies have emerged with dominant market shares, potentially impeding access to essential drugs and driving up price